CAMTEK LTD (CAMT) Stock Analysis

Price updated 4 days ago · SEC data refreshed 3 months ago · Not investment advice

CAMTEK LTD

CAMT Healthcare Optical Instruments & Lenses📄 SEC filings ↗
Valuation N/A
▾ What's in the 43/100 risk score? (higher = riskier)
Fundamental health (43%) 22/100 → +9.4
leverage 20/100 · FCF trend 25/100 · Altman Z not scored — input unavailable (see Financial Health)
Smart money (short interest + insider buying) (31%) 79/100 → +24.8
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total43/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.

💵 Price $147.97 · 4 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read CAMT

We are not publishing an intrinsic value for this one — the section below says exactly why. Everything on this page that comes straight from the filings and the tape is still here; treat the missing valuation as a known gap, not as a verdict on the business.

Where to start — the sections that matter most for this stock
  1. 1 Reported earnings & margins ↓
    What the company actually reported — unaffected by the valuation being held.
  2. 2 Balance sheet & book value ↓
    Assets, liabilities and equity as filed.
  3. 3 Who's selling & betting against it ↓
    Insider and short-interest behaviour needs no valuation model.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ A share-count quirk blocked the per-share math

The share count we read for CAMT looks wrong — common for multi-class / founder-controlled filers that report shares per share-class. That makes per-share figures (including intrinsic value) misleading, so we suppressed them. The company's total financials below are sound.

What to use instead: Lean on the totals — revenue, net income, cash flow — and the balance sheet. Multi-class share counts are being corrected; once fixed, the per-share valuation returns automatically.

This note is only about the single DCF fair-value number — CAMT's full financial statements, health scores, and written analysis are all below.

Loading insider & short-seller data…
Checking filings for failure warnings…

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
6 / 9
Mediocre
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income $50.7M in FY2025.
  • Positive operating cash flow
    Operating cash flow $141.9M (was $122.2M the prior year).
  • Cash flow backs up reported profit
    Operating cash flow $141.9M vs net income $50.7M.
  • Return on assets improving
    Return on assets 4.0% vs 13.3% a year ago.
    Why this matters: Is the company squeezing more profit out of each dollar of assets than last year? Rising = getting more efficient; falling = the opposite.
  • Debt load (vs assets)
    The filing reports no interest-bearing debt in either year (total assets $1,259.8M).
  • Short-term liquidity (current ratio)
    Current ratio 8.35x vs 5.00x a year ago.
  • Share count (dilution)
    Share count rose 1.2% (0.0M → 0.0M year-over-year).
    Why this matters: Issuing lots of new shares splits the pie into more pieces, shrinking your slice. Stable or falling share count protects existing owners.
  • Pricing power (gross margin)
    Gross margin 50.5% vs 48.9% a year ago.
  • Sales per asset (asset turnover)
    Asset turnover 0.39x vs 0.48x a year ago.
    Why this matters: Asset turnover measures how much revenue each dollar of assets generates. Rising = more productive use of the asset base.

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

Price$147.97
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

A standard discounted cash flow?DCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation →
valuation is not meaningful for Camtek due to data/units issues, specifically unreliable shares data which suppresses per-share values. Investors are likely focused on the company's consistent revenue growth and positive profitability, as evidenced by its 16.5% annual revenue growth and positive net income for the past five years. The market is betting on continued expansion in its niche. The number one quantifiable risk is the data reliability issue that prevents a standard valuation.

⚠️ Extreme valuation (P/IV 0.0046x, IV $37172.15 vs price $171.66); output dominated by data/units issue (often a multi-class share-count mismatch). Suppressed.

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

Per-share economics aren't reliable for this filer. Its income statement or share count isn't fully reported to SEC EDGAR (common for foreign private issuers and thinly-disclosed OTC names), so we don't break it down per share here — the figures would be misleading. See the financial tables below for what is reported.

What you actually need to decide

Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

🐂 The Bull Case
Camtek's revenue must continue its 16.5%/yr growth trajectory, driven by sustained demand in advanced semiconductor manufacturing, to justify its market valuation.
🐻 The Bear Case
The data/units issue, which suppresses per-share values, implies a fundamental uncertainty in valuing the company, and if not resolved, could hinder investor confidence.
📌 Signposts to watch — update your view as these print
  • Continued revenue growth rates above 15%
  • Maintenance of gross margins above 50%
  • Resolution of data reliability issues for per-share metrics

The trend, in plain numbers (FY2024 → FY2025, latest reported)

Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

✅ Improving
  • Revenue grew +16% to $496.1M.
  • Free cash flow rose to $110.6M.
  • Gross margin improved to 50% (+2 pts).
⚠ Worsening
  • Net income fell -57% to $50.7M.

Management & Leadership

Rafi Amit serves as the Chief Executive Officer of Camtek, a role he has held for a significant period, guiding the company's strategic direction in the semiconductor industry. He is supported by a team focused on operational execution and technological advancement.

Rafi Amit
Chief Executive Officer
Moshe Eisenberg
Chief Financial Officer

What They Make

Camtek develops and manufactures metrology and inspection equipment for the semiconductor industry, primarily serving manufacturers of advanced packaging, MEMS, and CMOS image sensors.

End Markets

Semiconductor manufacturingAdvanced packagingMEMS

Revenue Drivers

Metrology equipment sales
Inspection equipment sales
Service and support
Beta: 1.79

Why Is It Priced Like This?

Why Customers Pay

Enhanced yield in chip manufacturing
Improved quality control
Increased production efficiency
No discounted-cash-flow value for this filer We aren't publishing a discounted-cash-flow value here: the model's output failed our plausibility checks, so showing it would imply more precision than we have.

What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.

The market is pricing Camtek based on expectations of continued growth in the semiconductor sector and the company's ability to maintain its positive profitability and operating cash flow. With revenue growing at 16.5% annually over four years and positive net income for five consecutive years, investors are likely valuing its future growth potential rather than current cash flow, which is difficult to assess on a per-share basis due to data issues.

Business Model & Valuation

How They Make Money

Sales of metrology systems
Sales of inspection systems
After-sales service and support contracts

The company has positive operating cash flow for the past five years, indicating self-funding capabilities, and maintains an adequate current ratio of 8.35.

Free Cash Flow DCF Strong franchise

Standard FCF DCF: positive free cash flow in a sector suited for cash-flow-based valuation. High P/FCF (71x) - market pricing significant growth. Extended fade horizon (5→7 years)

Show advanced inputs
Revenue Growth16.5%
Eps Growth-6.7%
Historical Fcf Growth21.3%
Sector Default10.0%
Best Estimate14.5%
Methodblend(70% revenue_cagr, 30% sector)
Growth Basistotal

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Growth stage

Moat Signals

Specialized technology in semiconductor inspection
High switching costs for customers
Strong customer relationships in niche markets

Revenue has grown from $270M to $496M over four years, at 16.5%/yr, and net income has been positive for 5/5 years.

Geography & Markets

Camtek is headquartered in Israel but operates globally, with significant sales in major semiconductor manufacturing regions across Asia, North America, and Europe. Specific geographic revenue percentages are not available from current data sources.

Geographic Risks

Cyclicality of the semiconductor industry
Reliance on a few key customers or regions

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape neutral - aligned.
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
48.4NeutralMomentum is balanced — neither overbought nor oversold.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BearishLine below signalThe fast trend is below the slow trend — short-term momentum is currently downward.
50-Day Average$175.55Price below (-15.7%)Price below its 50-day average = near-term downtrend.
200-Day Average$133.79Price aboveThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
50 vs 200 CrossGolden50-day above 200-dayA "golden cross" — the medium trend has overtaken the long trend (often read as bullish).

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (2 notes — click to expand/collapse)

Guardrail Notes (2)
  • Extreme valuation (P/IV withheld — see the note above); output dominated by data/units issue (often a multi-class share-count mismatch). Suppressed.
  • DATA UNAVAILABLE: per-share values suppressed due to missing/unreliable shares data.

Financial Statements (5-year tables — click to expand)

From CAMTEK LTD's SEC filings (EDGAR).

Income (5yr)

YearRevenueNet IncomeEPS
2025496.1M50.7M$1.04
2024429.2M118.5M$2.42
2023315.4M78.6M$1.63
2022320.9M79.9M$1.68
2021269.7M60.3M$1.34

Cash Flow (5yr)

YearOperating CFCapEx− SBC & adj.Free Cash Flow
2025 141.9M 14.4M 16.9M 110.6M
2024 122.2M 10.1M 14.5M 97.6M
2023 79.3M 8.1M 12.6M 58.6M
2022 57.8M 8.2M 10.5M 39.1M
2021 61.0M 4.1M 5.8M 51.1M

How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: 141.9M − 14.4M − 16.9M (SBC & adj.) = 110.6M. This is the same owner-earnings FCF definition the valuation model uses.

Balance Sheet

Total Assets1.3B
Total Liabilities642.8M
Equity617.0M

Similar companies worth a look

Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $CAMT — free insider alerts
One email when an insider buys $CAMT on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.